Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
East Avenue Dentistry PLLC
mi
from
Rochester, NY
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Updated: 1/1/1970
East Avenue Dentistry PLLC
mi
from
Rochester, NY
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Janice K. Pliszczak, DDS
mi
from
Syracuse, NY
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Updated: 1/1/1970
Janice K. Pliszczak, DDS
mi
from
Syracuse, NY
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Laurence H Stone, DDS
mi
from
Doylestown, PA
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Updated: 1/1/1970
Laurence H Stone, DDS
mi
from
Doylestown, PA
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Dr. Jeannette Abboud-Niemczyk
mi
from
Drexel Hill, PA
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Updated: 1/1/1970
Dr. Jeannette Abboud-Niemczyk
mi
from
Drexel Hill, PA
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Allan J Horowitz, DMD
mi
from
King of Prussia, PA
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Updated: 1/1/1970
Allan J Horowitz, DMD
mi
from
King of Prussia, PA
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Dr. Julie Ann Barna
mi
from
Lewisburg, PA
Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial
Resin Based Composite Occlusal Restoration Postoperative Hypersensitivity: Randomized Comparative Effectiveness Research Trial
Status: Archived
Updated: 1/1/1970
Dr. Julie Ann Barna
mi
from
Lewisburg, PA
Efficacy of Botulinum Toxin Injections in the Rectus Femoris to Treat Stiff Knee Gait Following Acquired Brain Injury
Randomized Controlled Trial on the Effects of Botulinum Toxin Injections in the Rectus Femoris on Gait Function in Stiff Knee Gait Following Acquired Brain Injury
Status: Archived
Mary Free Bed Rehabilitation Hospital
mi
from
Grand Rapids, MI
Efficacy of Botulinum Toxin Injections in the Rectus Femoris to Treat Stiff Knee Gait Following Acquired Brain Injury
Randomized Controlled Trial on the Effects of Botulinum Toxin Injections in the Rectus Femoris on Gait Function in Stiff Knee Gait Following Acquired Brain Injury
Status: Archived
Updated: 1/1/1970
Mary Free Bed Rehabilitation Hospital
mi
from
Grand Rapids, MI
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Clinical Research Facility
mi
from
Phoenix, AZ
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Phoenix, AZ
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Clinical Research Facility
mi
from
San Diego, CA
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
San Diego, CA
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Clinical Research Facility
mi
from
Atlanta, GA
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Atlanta, GA
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Clinical Research Facility
mi
from
Des Moines, IA
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Des Moines, IA
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Clinical Research Facility
mi
from
Louisville, KY
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Louisville, KY
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Clinical Research Facility
mi
from
Baltimore, MD
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Baltimore, MD
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Clinical Research Facility
mi
from
Ayer, MA
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Ayer, MA
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Clinical Research Facility
mi
from
Duluth, MN
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Duluth, MN
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Clinical Research Facility
mi
from
Teaneck, NJ
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Teaneck, NJ
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Clinical Research Facility
mi
from
Bronx, NY
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Bronx, NY
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Clinical Research Facility
mi
from
Asheville, NC
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Asheville, NC
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Clinical Research Facility
mi
from
Akron, OH
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Akron, OH
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Clinical Research Facility
mi
from
Chattanooga, TN
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Chattanooga, TN
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Clinical Research Facility
mi
from
Houston, TX
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Houston, TX
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Clinical Research Facility
mi
from
Salt Lake City, UT
Efficacy and Safety Study of BIIB017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Salt Lake City, UT
Amicar Pharmacokinetics of Children Having Craniofacial Surgery
Pharmacokinetics of Epsilon-Aminocaproic Acid in Children Undergoing Craniofacial Reconstruction Surgery
Status: Archived
Saint Peter's University Hospital
mi
from
New Brunswick, NJ
Amicar Pharmacokinetics of Children Having Craniofacial Surgery
Pharmacokinetics of Epsilon-Aminocaproic Acid in Children Undergoing Craniofacial Reconstruction Surgery
Status: Archived
Updated: 1/1/1970
Saint Peter's University Hospital
mi
from
New Brunswick, NJ
Repetitive Transcranial Magnetic Stimulation (rTMS) to Promote Hand Recovery in Stroke
rTMS and Motor Learning Training to Promote Recovery From Hemiparesis
Status: Archived
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Repetitive Transcranial Magnetic Stimulation (rTMS) to Promote Hand Recovery in Stroke
rTMS and Motor Learning Training to Promote Recovery From Hemiparesis
Status: Archived
Updated: 1/1/1970
University of Minnesota Medical Center
mi
from
Minneapolis, MN
The Relative Prevalence and Severity of Autonomic Nervous System Dysfunction
The Relative Prevalence and Severity of Autonomic Nervous System Dysfunction in Diabetic Patients Undergoing Retinal Surgery
Status: Archived
Callahan Eye Foundation Hospital
mi
from
Birmingham, AL
The Relative Prevalence and Severity of Autonomic Nervous System Dysfunction
The Relative Prevalence and Severity of Autonomic Nervous System Dysfunction in Diabetic Patients Undergoing Retinal Surgery
Status: Archived
Updated: 1/1/1970
Callahan Eye Foundation Hospital
mi
from
Birmingham, AL
Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)
Phase IIA Trial: Tretinoin and Pioglitazone HCL Combination Therapy in Amyotrophic Lateral Sclerosis
Status: Archived
Phoenix Neurological Associates
mi
from
Phoenix, AZ
Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)
Phase IIA Trial: Tretinoin and Pioglitazone HCL Combination Therapy in Amyotrophic Lateral Sclerosis
Status: Archived
Updated: 1/1/1970
Phoenix Neurological Associates
mi
from
Phoenix, AZ
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Clinical Trial Facility
mi
from
Denver, CO
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Denver, CO
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Clinical Trial Facility
mi
from
Centralia, IL
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Centralia, IL
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Clinical Trial Facility
mi
from
Bettendorf, IA
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Bettendorf, IA
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Clinical Trial Facility
mi
from
Louisville, KY
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Louisville, KY
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Clinical Trial Facility
mi
from
Jackson, MS
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Jackson, MS
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Clinical Trial Facility
mi
from
St Louis, MO
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
St Louis, MO
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Clinical Trial Facility
mi
from
Albany, NY
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Albany, NY
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Clinical Trial Facility
mi
from
Charlotte, NC
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Charlotte, NC
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Clinical Trial Facility
mi
from
Lima, OH
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Lima, OH
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Clinical Trial Facility
mi
from
Medford, OR
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Medford, OR
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Clinical Trial Facility
mi
from
Nashville, TN
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Nashville, TN
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Clinical Trial Facility
mi
from
Austin, TX
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Austin, TX
Social Skills and Anxiety Reduction Treatment for Children and Adolescents With Autism Spectrum Disorders
A Cognitive-Behavioral Intervention for Children With Autism Spectrum Disorders
Status: Archived
Virginia Polytechnic Institute and State University
mi
from
Blacksburg, VA
Social Skills and Anxiety Reduction Treatment for Children and Adolescents With Autism Spectrum Disorders
A Cognitive-Behavioral Intervention for Children With Autism Spectrum Disorders
Status: Archived
Updated: 1/1/1970
Virginia Polytechnic Institute and State University
mi
from
Blacksburg, VA
Melatonin for Sleep in Children With Autism
Melatonin for Sleep in Children With Autism: Safety Tolerability and Dose
Status: Archived
Vanderiblt University Medical Center
mi
from
Nashville, TN
Melatonin for Sleep in Children With Autism
Melatonin for Sleep in Children With Autism: Safety Tolerability and Dose
Status: Archived
Updated: 1/1/1970
Vanderiblt University Medical Center
mi
from
Nashville, TN
Long-term Cardiac Monitoring After Cryptogenic Stroke (CMACS)
Long-term Cardiac Monitoring After Cryptogenic Stroke (CMACS): A Pilot Randomized Trial
Status: Archived
Unversity of California, San Francisco
mi
from
San Francisco, CA
Long-term Cardiac Monitoring After Cryptogenic Stroke (CMACS)
Long-term Cardiac Monitoring After Cryptogenic Stroke (CMACS): A Pilot Randomized Trial
Status: Archived
Updated: 1/1/1970
Unversity of California, San Francisco
mi
from
San Francisco, CA
Stroke Team Remote Evaluation Using a Digital Observation Camera- Long Term Outcomes(STRokE DOC-LTO)
An Observational Study to Evaluate the Long Term Outcomes of Patients Previously Enrolled in the STRokE DOC Telemedicine Clinical Trial.
Status: Archived
UC San Diego Medical Center
mi
from
San Diego, CA
Stroke Team Remote Evaluation Using a Digital Observation Camera- Long Term Outcomes(STRokE DOC-LTO)
An Observational Study to Evaluate the Long Term Outcomes of Patients Previously Enrolled in the STRokE DOC Telemedicine Clinical Trial.
Status: Archived
Updated: 1/1/1970
UC San Diego Medical Center
mi
from
San Diego, CA
Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA)
Comparison of Standard 1.5 Versus 3T Optimized Protocols in Patients Treated With Glatiramer Acetate. A Conventional and Non-Conventional MRI Study
Status: Archived
University at Buffalo - Buffalo General Hospital
mi
from
Buffalo, NY
Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA)
Comparison of Standard 1.5 Versus 3T Optimized Protocols in Patients Treated With Glatiramer Acetate. A Conventional and Non-Conventional MRI Study
Status: Archived
Updated: 1/1/1970
University at Buffalo - Buffalo General Hospital
mi
from
Buffalo, NY
Efficacy and Safety Study of Botulinum Neurotoxin A With Rehabilitation Versus Botulinum Neurotoxin A Alone in Treatment of Post-stroke Spasticity
Open-label, Parallel Study to Determine the Efficacy and Safety of Botulinum Neurotoxin A Paired With Rehabilitation Therapy vs. Botulinum Neurotoxin A Alone for the Treatment of Post-stroke Upper Limb Spasticity
Status: Archived
New Mexico VA Health Care System
mi
from
Albuquerque, NM
Efficacy and Safety Study of Botulinum Neurotoxin A With Rehabilitation Versus Botulinum Neurotoxin A Alone in Treatment of Post-stroke Spasticity
Open-label, Parallel Study to Determine the Efficacy and Safety of Botulinum Neurotoxin A Paired With Rehabilitation Therapy vs. Botulinum Neurotoxin A Alone for the Treatment of Post-stroke Upper Limb Spasticity
Status: Archived
Updated: 1/1/1970
New Mexico VA Health Care System
mi
from
Albuquerque, NM
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type
A 24 Week, Prospective, Randomized, Parallel-Group, Double-Blind, Multi-Center Study Comparing the Effects of Rivastigmine Patch 15 cm2 vs. Rivastigmine Patch 5 cm2 on ACTivities of Daily Living and CognitION in Patients With Severe Dementia of the Alzheimer's Type (ACTION).
Status: Archived
Clinical Research Advantage/Neuro. Physicians of Arizona, Inc
mi
from
Gilbert, AZ
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type
A 24 Week, Prospective, Randomized, Parallel-Group, Double-Blind, Multi-Center Study Comparing the Effects of Rivastigmine Patch 15 cm2 vs. Rivastigmine Patch 5 cm2 on ACTivities of Daily Living and CognitION in Patients With Severe Dementia of the Alzheimer's Type (ACTION).
Status: Archived
Updated: 1/1/1970
Clinical Research Advantage/Neuro. Physicians of Arizona, Inc
mi
from
Gilbert, AZ
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type
A 24 Week, Prospective, Randomized, Parallel-Group, Double-Blind, Multi-Center Study Comparing the Effects of Rivastigmine Patch 15 cm2 vs. Rivastigmine Patch 5 cm2 on ACTivities of Daily Living and CognitION in Patients With Severe Dementia of the Alzheimer's Type (ACTION).
Status: Archived
Northwest Neuro Specialist
mi
from
Tucson, AZ
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type
A 24 Week, Prospective, Randomized, Parallel-Group, Double-Blind, Multi-Center Study Comparing the Effects of Rivastigmine Patch 15 cm2 vs. Rivastigmine Patch 5 cm2 on ACTivities of Daily Living and CognitION in Patients With Severe Dementia of the Alzheimer's Type (ACTION).
Status: Archived
Updated: 1/1/1970
Northwest Neuro Specialist
mi
from
Tucson, AZ
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type
A 24 Week, Prospective, Randomized, Parallel-Group, Double-Blind, Multi-Center Study Comparing the Effects of Rivastigmine Patch 15 cm2 vs. Rivastigmine Patch 5 cm2 on ACTivities of Daily Living and CognitION in Patients With Severe Dementia of the Alzheimer's Type (ACTION).
Status: Archived
IHS Research Center Incorporated
mi
from
Conway, AR
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type
A 24 Week, Prospective, Randomized, Parallel-Group, Double-Blind, Multi-Center Study Comparing the Effects of Rivastigmine Patch 15 cm2 vs. Rivastigmine Patch 5 cm2 on ACTivities of Daily Living and CognitION in Patients With Severe Dementia of the Alzheimer's Type (ACTION).
Status: Archived
Updated: 1/1/1970
IHS Research Center Incorporated
mi
from
Conway, AR
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type
A 24 Week, Prospective, Randomized, Parallel-Group, Double-Blind, Multi-Center Study Comparing the Effects of Rivastigmine Patch 15 cm2 vs. Rivastigmine Patch 5 cm2 on ACTivities of Daily Living and CognitION in Patients With Severe Dementia of the Alzheimer's Type (ACTION).
Status: Archived
The Research & Education Inst. of Alta Bates Summit Med. Group
mi
from
Berkeley, CA
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type
A 24 Week, Prospective, Randomized, Parallel-Group, Double-Blind, Multi-Center Study Comparing the Effects of Rivastigmine Patch 15 cm2 vs. Rivastigmine Patch 5 cm2 on ACTivities of Daily Living and CognitION in Patients With Severe Dementia of the Alzheimer's Type (ACTION).
Status: Archived
Updated: 1/1/1970
The Research & Education Inst. of Alta Bates Summit Med. Group
mi
from
Berkeley, CA
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type
A 24 Week, Prospective, Randomized, Parallel-Group, Double-Blind, Multi-Center Study Comparing the Effects of Rivastigmine Patch 15 cm2 vs. Rivastigmine Patch 5 cm2 on ACTivities of Daily Living and CognitION in Patients With Severe Dementia of the Alzheimer's Type (ACTION).
Status: Archived
ATP Clinical Research, Inc.
mi
from
Costa Mesa, CA
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type
A 24 Week, Prospective, Randomized, Parallel-Group, Double-Blind, Multi-Center Study Comparing the Effects of Rivastigmine Patch 15 cm2 vs. Rivastigmine Patch 5 cm2 on ACTivities of Daily Living and CognitION in Patients With Severe Dementia of the Alzheimer's Type (ACTION).
Status: Archived
Updated: 1/1/1970
ATP Clinical Research, Inc.
mi
from
Costa Mesa, CA